Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - albutrepenonacog alfa 250 [iu];  ;   - powder for injection - 250 iu - active: albutrepenonacog alfa 250 [iu]     excipient: hydrochloric acid mannitol polysorbate 80 sodium citrate dihydrate sucrose water for injection - idelvion is indicated in all patients with haemophilia b for: - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - control and prevention of bleeding episodes - control and prevention of bleeding in the perioperative setting.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - albutrepenonacog alfa 500 [iu];  ;   - powder for injection - 500 iu - active: albutrepenonacog alfa 500 [iu]     excipient: hydrochloric acid mannitol polysorbate 80 sodium citrate dihydrate sucrose water for injection - idelvion is indicated in all patients with haemophilia b for: - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - control and prevention of bleeding episodes - control and prevention of bleeding in the perioperative setting.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - factor ix, quantity: 3500 iu - solution - excipient ingredients: - idelvion is indicated in all patients with haemophilia b for:,? routine prophylaxis to prevent or reduce the frequency of bleeding episodes,? control and prevention of bleeding episodes,? control and prevention of bleeding in the perioperative setting.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - factor ix, quantity: 2000 iu - solution - excipient ingredients: - idelvion is indicated in all patients with haemophilia b for:,? routine prophylaxis to prevent or reduce the frequency of bleeding episodes,? control and prevention of bleeding episodes,? control and prevention of bleeding in the perioperative setting.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - factor ix, quantity: 1000 iu - solution - excipient ingredients: - idelvion is indicated in all patients with haemophilia b for:,? routine prophylaxis to prevent or reduce the frequency of bleeding episodes,? control and prevention of bleeding episodes,? control and prevention of bleeding in the perioperative setting.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - factor ix, quantity: 500 iu - solution - excipient ingredients: - idelvion is indicated in all patients with haemophilia b for:,? routine prophylaxis to prevent or reduce the frequency of bleeding episodes,? control and prevention of bleeding episodes,? control and prevention of bleeding in the perioperative setting.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - factor ix, quantity: 250 iu - solution - excipient ingredients: - idelvion is indicated in all patients with haemophilia b for:,? routine prophylaxis to prevent or reduce the frequency of bleeding episodes,? control and prevention of bleeding episodes,? control and prevention of bleeding in the perioperative setting.

Saudi - Kiingereza - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

csl behring, germany - albutrepenonacog alfa (recombinant fusion protein linking coagulation factor ix with albumin) - powder and solvent for solution for injection - 250 iu,

Saudi - Kiingereza - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

csl behring, germany - albutrepenonacog alfa (recombinant fusion protein linking coagulation factor ix with albumin) - powder and solvent for solution for injection - 500 iu,

Saudi - Kiingereza - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

csl behring, germany - albutrepenonacog alfa (recombinant fusion protein linking coagulation factor ix with albumin) - powder and solvent for solution for injection - 1000 iu,